INSIGHTS ON DRUG DEVELOPMENT
-
3D Cell Culture Reveals Undetectable Drug Efficacy In Traditional Systems
Drug discovery now targets cancer stem cells (CSCs) to achieve long-term tumor eradication, which moves beyond traditional chemotherapeutics. Discover an advanced screening platform that better predicts CSC inhibitor efficacy.
-
Utilizing The Colon Intestine-Chip To Investigate Mechanisms Of Gastrointestinal Disease
What are the application and benefits of Organ-Chips and what makes them superior to organoids in the study of GI-related diseases?
-
Characterizing Binding Interactions By ITC
Isothermal Titration Calorimetry is a powerful technique for analyzing biochemical binding events, which is crucial for understanding molecular interactions and enzyme kinetics in biomedical research.
-
Unlocking The Future: Exploring Cutting-Edge Cell And Gene Therapies
Explore the transformative potential of cutting-edge cell and gene therapies, focusing on CAR-T cell therapy, CRISPR-Cas9 gene editing, and other advanced approaches.
-
A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics11/7/2025
Learn about a streamlined workflow that improves reproducibility, reduces contamination, and simplifies single-cell proteomics with comparable results to FACS.
-
How To Reduce Batch Loss In Biopharma Production12/12/2025
Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.
-
Aggregate Analysis Of Semaglutide12/11/2025
Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.
-
Aggregate Analysis Of Tirzepatide12/11/2025
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
Manufacturing CAR T Cell Therapies: Challenges, Insights And Solutions6/16/2025
Manufacturing patient-specific cell therapies is a complex, multi-step process. Addressing key hurdles in production time, scalability, and cost is crucial to making these vital treatments more accessible.
DRUG DEVELOPMENT SOLUTIONS
-
Our solutions are tailored to guide and optimize your efforts, so you can be confident in your development strategy and execution plan. While we have a wide range of offerings ready and available, we are driven by one goal—to help you successfully realize yours.
-
THUNDER Imager EM Cryo CLEM
In-depth understanding of cellular structural biology
The THUNDER Imager EM Cryo CLEM is a cryo light microscope featuring opto-digital THUNDER technology. It provides the imaging data and secure cryo conditions you need for successful experimental investigations concerning structural biology. Precisely identify cellular structures of interest thanks to high resolution, haze-free imaging with THUNDER technology, then transfer the specimen seamlessly to your EM.
-
Our comprehensive pharmaceutical development service offering includes new drug development, early stage formulation and analytical development for both highly potent and non-potent drug products.
-
Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.
-
From safety considerations to kid-friendly dosing, we can help you get your pediatric formulation right.